Stephen Dale M.D.
Net Worth
Last updated:
What is Stephen Dale M.D. net worth?
The estimated net worth of Dr. Stephen Dale M.D. is at least $1,441,821 as of 30 Jan 2024. He owns shares worth $284,529 as insider, has earned $359,432 from insider trading and has received compensation worth at least $797,860 in Kura Oncology, Inc..
What is the salary of Stephen Dale M.D.?
Dr. Stephen Dale M.D. salary is $398,930 per year as Chief Medical Officer in Kura Oncology, Inc..
How old is Stephen Dale M.D.?
Dr. Stephen Dale M.D. is 53 years old, born in 1972.
What stocks does Stephen Dale M.D. currently own?
As insider, Dr. Stephen Dale M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | Chief Medical Officer | 38,817 | $7.33 | $284,529 |
What does Kura Oncology, Inc. do?
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Stephen Dale M.D. insider trading
Kura Oncology, Inc.
Dr. Stephen Dale M.D. has made 5 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 4,825 units of KURA stock worth $103,979 on 30 Jan 2024.
The largest trade he's ever made was exercising 4,840 units of KURA stock on 27 Jan 2023. As of 30 Jan 2024 he still owns at least 38,817 units of KURA stock.
Kura Oncology key executives
Kura Oncology, Inc. executives and other stock owners filed with the SEC:
- Dr. Marc Grasso (52) Chief Financial Officer & Chief Bus. Officer
- Dr. Stephen Dale M.D. (53) Chief Medical Officer
- Dr. Troy Edward Wilson (56) Chairman, Chief Executive Officer & Pres
- Ms. Kathleen Ford (78) Chief Operating Officer
- Ms. Kirsten Flowers (50) Chief Commercial Officer